14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AHG vs PDX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, PIMCO Dynamic Income Strategy Fund (PDX) captures the overall head-to-head institutional edge over Akso Health Group ADS (AHG) on higher Unified Composite conviction (45.3/100 HOLD vs. 42.6/100 HOLD) after splitting the core matrix 4–4 (led by composite factor balance), while AHG wins 5–0 across the 6-pillar growth and valuation breakdown. AHG trades at $1.33 (N/M Forward P/E, -28.9% operating margin) versus PDX at $20.06 (N/M Forward P/E, N/A operating margin).
Growth vs. Quality Trade-Off: PDX earns the overall head-to-head edge with a stronger Unified Composite Score (45.3/100 HOLD vs. AHG 42.6/100 HOLD) and 0.19β · 16% Vol risk profile, whereas AHG leads top-line expansion (-12.9% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: AHG trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 54.2); meanwhile PDX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AHG vs PDX. Trailing 12-month operating profitability (AHG -28.9% vs PDX N/A) and valuation multiples (AHG N/M vs PDX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $1.1B market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ AHG vs PDX Key Questions & Quantitative Answers
As of Nov 16, 2026, PIMCO Dynamic Income Strategy Fund (PDX) captures the overall head-to-head institutional edge over Akso Health Group ADS (AHG) on higher Unified Composite conviction (45.3/100 HOLD vs. 42.6/100 HOLD) after splitting the core matrix 4–4 (led by composite factor balance), while AHG wins 5–0 across the 6-pillar growth and valuation breakdown. AHG trades at $1.33 (N/M Forward P/E, -28.9% operating margin) versus PDX at $20.06 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: PDX earns the overall head-to-head edge with a stronger Unified Composite Score (45.3/100 HOLD vs. AHG 42.6/100 HOLD) and 0.19β · 16% Vol risk profile, whereas AHG leads top-line expansion (-12.9% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AHG trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 54.2); meanwhile PDX is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AHG leads the Growth & Scale pillar: AHG posts -12.9% YoY revenue growth and +0.0% YoY earnings growth on $14M TTM revenue (-0.1% gross margin, -28.9% operating margin), compared with PDX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, AHG generates $14M in USD-normalized revenue versus N/A for PDX. In operating R&D and SG&A reinvestment, AHG deploys 28.8% of Rev ($4.0M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PDX.
AHG screens cheaper on headline valuation multiples. AHG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 76.8x EV/Revenue (-11.8% EBITDA margin), whereas PDX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AHG (-9.8% ROE) versus PDX (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, AHG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.16β · 97% Vol realized risk). By comparison, PDX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 16% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.